awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q30715455-81925993-566C-42EA-A1D4-E7B27C806852
Q30715455-81925993-566C-42EA-A1D4-E7B27C806852
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30715455-81925993-566C-42EA-A1D4-E7B27C806852
Analysis of trial data for infliximab and golimumab: baseline C-reactive protein level and prediction of therapeutic response in patients with psoriatic arthritis.
P2860
Q30715455-81925993-566C-42EA-A1D4-E7B27C806852
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30715455-81925993-566C-42EA-A1D4-E7B27C806852
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c0df1d843127b7989d1b2b80db36ad37be5733eb
P2860
Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial.